French healthcare company makes $1.2bn AI drug discovery deal

Partnership with San Francisco-based software biotech initially focuses on compounds for five targets | Company uses machine learning to enable structure-based drug design.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

French pharma firm inks deal with tech provider

11 October 2022 The partnership aims to progress drug discovery and development | Tech platform accelerates trials and provides higher quality trial data.

Medtech

PTAB invalidates Sanofi injector patent

1 April 2021 Mylan Pharmaceuticals has succeeded in getting the Patent Trial and Appeal board (PTAB) to invalidate an injector patent held by French pharmaceutical company Sanofi

Americas

Sanofi unit takes CSL to court over haemophilia therapy

5 March 2020 Biotech company Bioverativ has accused CSL Behring of infringing three patents covering its haemophilia B treatment Alprolix.